Press Releases
Press Release filters
Sign up to receive updates from mdxhealth
Click the button below to fill in your contact information and receive updates from mdxhealth.
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance IRVINE, CA, and HERSTAL, BELGIUM – January 8,
MDxHealth annonce la réalisation de sa transition vers une cotation unique sur le Nasdaq
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE 18 DECEMBRE 2023, 01:00 ET / 07:00 CET IRVINE, CA, et HERSTAL, BELGIQUE – 18 decembre 2023 – MDxHealth
MDxHealth Announces Completion of Transition to Single Listing on Nasdaq
NEWS RELEASE – REGULATED INFORMATIONDECEMBER 18, 2023, 1:00 AM ET / 07:00 AM CET MDxHealth Announces Completion of Transition to Single Listing on
MDxHealth annonce la réalisation de l’échange obligatoire d’ADS et le début de la période de transition vers une cotation unique sur le Nasdaq
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE 27 NOVEMBRE 2023, 1:00 EDT / 7:00 CET IRVINE, CA, et HERSTAL, BELGIQUE – 27 novembre 2023 – MDxHealth
MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq
NEWS RELEASE – REGULATED INFORMATIONNOVEMBER 27, 2023, 1:00 am ET / 7:00 am CET MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition
MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference
NEWS RELEASENovember 14, 2023, 4PM ET/ 22:00 CET MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference IRVINE, CA,
MDxHealth annonce la réalisation de son regroupement d’actions, et la mise à jour des actions et des droits de vote en circulation
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE INFORMATION PRIVILÉGIÉE 13 NOVEMBRE 2023, 16:00 ET / 22:00 CET MDxHealth annonce la réalisation de son regroupement d’actions, et
MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONNOVEMBER 13, 2023, 4:00 PM ET / 22:00 CET MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding
MDxHealth communique ses résultats pour le troisième trimestre et la période de neuf mois clôturée le 30 septembre 2023
COMMUNIQUÉ DE PRESSE — INFORMATIONS RÉGLEMENTÉES 8 NOVEMBRE 2023, 16 h 00 EDT/22 h 00 CET MDxHealth communique ses résultats pour le troisième trimestre et la période de neuf mois
MDxHealth annonce l’approbation par ses actionnaires de la proposition de transition vers une cotation unique des actions sur le Nasdaq, ainsi que les détails du regroupement d’actions
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE INFORMATION PRIVILÉGIÉE 6 NOVEMBRE 2023, 1:00 ET / 7:00 CET MDxHealth annonce l’approbation par ses actionnaires de la
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023
NEWS RELEASE – REGULATED INFORMATION8 NOVEMBER 2023, 4:00PM EDT / 22:00 CET MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended
MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONNOVEMBER 6, 2023, 1:00 AM ET / 7:00 CET MDxHealth Announces the Approval by its Shareholders of the
MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8
NEWS RELEASE25 OCTOBER 2023, 4PM ET / 22:00 CET MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8 Company to
Nouveau montant du capital et nouveau nombre d’actions de Mdxhealth
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE 20 octobre 2023, 16:00 EDT / 22:00 CET Nouveau montant du capital et nouveau nombre d’actions de Mdxhealth IRVINE, CA,
Mdxhealth’s New Share Capital Amount and New Number of Shares
NEWS RELEASE – REGULATED INFORMATION October 20, 2023, 4:00 PM EDT / 22:00 CET Mdxhealth’s New Share Capital Amount and New Number of Shares
MDxHealth Reports Preliminary Q3-2023 Revenues
NEWS RELEASE – INSIDE AND REGULATED INFORMATION9 OCTOBER 2023, 4PM ET / 22:00 CET MDxHealth Reports Preliminary Q3-2023 Revenues IRVINE, CA, and HERSTAL,
MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONOCTOBER 2, 2023, 4:00pm ET / 22:00 CET MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq
Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer
NEWS RELEASE September 26, 2023, 5:00PM EDT / 23:00 CET Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of
MDxHealth communique ses résultats financiers T2 et S1 2023
COMMUNIQUÉ DE PRESSE – INFORMATIONS RÉGLEMENTÉES 23 AOÛT 2023, 16 h 00 EDT, 22 h 00 CET MDxHealth communique ses résultats financiers T2 et S1 2023 Les revenus du T2 ont
MDxHealth Reports Q2 and Half Year 2023 Results
NEWS RELEASE – REGULATED INFORMATION23 AUGUST 2023, 4:00PM EDT / 22:00 CET MDxHealth Reports Q2 and Half Year 2023 Results Year-over-year Q2 revenues
